What is sPRAVATO®?

SPRAVATO® is a non-competitive N-methyl D-aspartate (NMDA) receptor antagonist indicated, in conjunction with oral antidepressant, for the treatment of:

-Treatment-Resistant Depression (TRD) in adults

-Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior